title: [Importance of appropiate clinical management of direct oral anticoagulants].
authors.affiliation: Unidad de Hemostasia y Trombosis, Hospital de la Santa Creu i Sant Pau, Barcelona, España. Electronic address: jmillon@santpau.cat.
authors.forename: Juan Antonio
authors.initials: JA
authors.lastname: Millón Caño
authors.affiliation: Unidad de Hemostasia y Trombosis, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
authors.forename: Noelia
authors.initials: N
authors.lastname: Vilalta Setó
authors.affiliation: Unidad de Hemostasia y Trombosis, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
authors.forename: José
authors.initials: J
authors.lastname: Mateo Arranz
authors.affiliation: Unidad de Hemostasia y Trombosis, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: Souto Andrés
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D000069604:Dabigatran / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D012189:Retrospective Studies; D000069552:Rivaroxaban / Q000627:therapeutic use*; D013030:Spain; D054556:Venous Thromboembolism / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D000069552:Rivaroxaban; D000069604:Dabigatran